Rat Npas4/Nxf ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_153626.1)

Cat. No.: vGMAAV000100

Pre-made Rat Npas4/Nxf Adeno-associated virus particle for Npas4 in-vivo study, mechanism of action (MOA) research and Npas4-associated gene therapy development.

At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name AAV serotype AAV Grade AAV quantity
vGMAAV000100 Rat Npas4 Adeno-associate virus(AAV) particle AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF Pilot Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
Research Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAAV000100
Gene Name Npas4
Accession Number NM_153626.1
Gene ID 266734
Species Rat
Product Type Adeno-associate virus(AAV) particle (overexpression)
Insert Length 2409 bp
Gene Alias Nxf
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag Null
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGTACCGATCCACCAAGGGCGCCTCCAAGGCGCGCCGCGACCAGATCAACGCCGAGATTCGGAACCTCAAGGAACTGCTGCCGTTGGCTGAAGCGGACAAGGTCCGGCTGTCCTACCTGCACATCATGAGTCTTGCCTGCATCTACACTCGCAAGGGTGTCTTCTTTGCTGGAGGCACTCCTTTGGCTGGCCCCACGGGGCTTCTCTCTGCTCAAGAGCTTGAAGACATAGTGGCAGCACTACCTGGATTTCTACTTGTGTTCACAGCTGAGGGGAAGTTGCTATACCTGTCGGAGAGTGTGAGCGAGCATCTGGGCCATTCTATGGTGGATCTGGTTGCCCAGGGTGACAGTATTTACGACATCATTGACCCTGCTGACCATCTCACTGTGCGCCAGCAGCTCACCATGCCCTCTGCTCTGGATGCTGATCGCCTTTTCCGTTGTCGATTTAACACATCCAAGTCCCTCCGGCGCCAGAGTGCAGGCAACAAACTGGTGCTTATTCGAGGTCGATTCCATGCTCACCCACCTGGGGCCTACTGGGCAGGAAACCCCGTGTTCACAGCTTTCTGTGCCCCACTGGAGCCAAGACCCCGTCCCGGCCCTGGCCCTGGCCCTGGCCCTGGTCCTGCCTCTCTCTTCCTGGCCATGTTCCAGAGCCGGCATGCTAAGGACCTAGCCCTACTGGACATTTCTGAAAGTGTCCTAATCTACCTGGGCTTTGAGCGCAGCGAACTGCTCTGTAAATCATGGTATGGACTGCTACACCCCGAGGACCTGGCCCACGCTTCTTCTCAACACTACCGCCTGTTGGCTGAAAATGGAGATATTCAGGCTGAAATGGTGGTGAGACTTCAAGCCAAGCATGGAGGCTGGACATGGATTTACTGCATGCTATACTCGGATGGTCCAGAAGGCCCTATTACTGCCAATAACTACCCTATCAGTGACACGGAAGCCTGGAGTCTTCGCCAGCAGCTAAACTCTGAAAACACCCAGGCAGCCTATGTCCTAGGAACCCCAGCTGTGCTACCCTCATTCTCTGAGAATGTCTTCTCCCAGGAGCACTGCTCTAATCCACTCTTTACACCAGCCCTGGGGACTCCTAGAAGTGCCAGCTTCCCCAGGGCCCCTGAACTAGGTGTGATCTCAACATCAGAAGAGCTTGCCCAACCCTCCAAAGAACTGGACTTCAGTTACCTGCCATTCCCTGCAAGGCCTGAGCCTTCCCTCCAAGCAGACTTGAGCAAGGATTTGGTGTGTACTCCACCTTACACACCCCACCAGCCAGGAGGCTGCGCCTTCCTCTTCAGCCTCCATGAACCCTTCCAGACTCACTTGCCCCCTCCATCCAGCTCTCTCCAAGAACAGCTGACGCCAAGCACGGTGACTTTCTCTGAACAGTTGACACCAAGCAGTGCAACCTTCCCAGATCCACTAACCAGTTCACTACAAGGACAGTTGACTGAAAGCTCAGCCAGAAGCTTTGAAGAACAATTGACTCCGTGCACCTCTACCTTCCCTGACCAGCTGCTTCCCAGCACTGCCACGTTCCCAGAACCTCTGGGTAGCCCCACCCATGAGCAGCTGACTCCTCCCAGCACAGCATTCCAAGCACATCTGAACAGTCCTAGCCAAACCTTCCCAGAGCAACTGAGCCCTAATCCTACCAAGACTTACTTCGCCCAGGAGGGATGCAGTTTTCTCTATGAGAAGTTGCCCCCAAGTCCTAGCAGCCCTGGTAATGGGGACTGTACACTCTTGGCCCTAGCTCAACTCCGGGGTCCCCTCTCTGTGGACGTCCCCCTGGTGCCTGAAGGCCTGCTCACACCTGAGGCCTCTCCAGTCAAGCAAAGTTTCTTCCACTATACAGAGAAAGAGCAGAATGAGATAGATCGTCTCATCCAGCAGATCAGCCAGTTGGCTCAGGGCATGGACAGGCCCTTCTCAGCTGAGGCTGGCACTGGGGGGCTGGAGCCACTTGGAGGGCTGGAGCCCCTGAACCCCAACCTGTCCCTGTCAGGGGCTGGACCCCCTGTGCTTAGCCTGGATCTTAAACCCTGGAAATGCCAGGAGCTGGACTTCTTGGTTGACCCTGATAATTTATTCCTGGAAGAGACGCCAGTGGAAGACATCTTCATGGATCTTTCTACTCCAGACCCCAATGGGGAATGGGGTTCAGGGGATCCTGAGGCAGAGGTCCCAGGAGGGACCCTGTCACCTTGCAACAACCTGTCCCCAGAAGATCACAGCTTCCTGGAGGACTTGGCCACCTATGAAACCGCCTTTGAGACAGGTGTCTCAACATTCCCCTATGAAGGGTTTGCTGATGAGTTGCATCAACTCCAGAGCCAAGTTCAAGACAGCTTCCATGAAGATGGAAGTGGAGGGGAACCAACGTTTTGA
ORF Protein Sequence MYRSTKGASKARRDQINAEIRNLKELLPLAEADKVRLSYLHIMSLACIYTRKGVFFAGGTPLAGPTGLLSAQELEDIVAALPGFLLVFTAEGKLLYLSESVSEHLGHSMVDLVAQGDSIYDIIDPADHLTVRQQLTMPSALDADRLFRCRFNTSKSLRRQSAGNKLVLIRGRFHAHPPGAYWAGNPVFTAFCAPLEPRPRPGPGPGPGPGPASLFLAMFQSRHAKDLALLDISESVLIYLGFERSELLCKSWYGLLHPEDLAHASSQHYRLLAENGDIQAEMVVRLQAKHGGWTWIYCMLYSDGPEGPITANNYPISDTEAWSLRQQLNSENTQAAYVLGTPAVLPSFSENVFSQEHCSNPLFTPALGTPRSASFPRAPELGVISTSEELAQPSKELDFSYLPFPARPEPSLQADLSKDLVCTPPYTPHQPGGCAFLFSLHEPFQTHLPPPSSSLQEQLTPSTVTFSEQLTPSSATFPDPLTSSLQGQLTESSARSFEEQLTPCTSTFPDQLLPSTATFPEPLGSPTHEQLTPPSTAFQAHLNSPSQTFPEQLSPNPTKTYFAQEGCSFLYEKLPPSPSSPGNGDCTLLALAQLRGPLSVDVPLVPEGLLTPEASPVKQSFFHYTEKEQNEIDRLIQQISQLAQGMDRPFSAEAGTGGLEPLGGLEPLNPNLSLSGAGPPVLSLDLKPWKCQELDFLVDPDNLFLEETPVEDIFMDLSTPDPNGEWGSGDPEAEVPGGTLSPCNNLSPEDHSFLEDLATYETAFETGVSTFPYEGFADELHQLQSQVQDSFHEDGSGGEPTF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMAAV000100 Rat Npas4 Adeno-associate virus(AAV) plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.